Prazosin

Prazosin

Clinical data
Routes of administration	Oral
ATC code	C02CA01 (WHO)
Legal status
Legal status	UK: POM (Prescription only)
Pharmacokinetic data
Protein binding	97%
Elimination half-life	2–3 hours
Identifiers
IUPAC name [4-(4-amino-6,7-dimethoxy-quinazolin-2-yl) piperazin-1-yl]-(2-furyl)methanone
CAS Number	19216-56-9
PubChem CID	4893
DrugBank	APRD00020
E number	{{#property:P628}}
ECHA InfoCard	{{#property:P2566}}
Chemical and physical data
Formula	C19H21N5O4
Molar mass	383.401 g/mol

WikiDoc Resources for Prazosin
Articles
Most recent articles on Prazosin Most cited articles on Prazosin Review articles on Prazosin Articles on Prazosin in N Eng J Med, Lancet, BMJ
Media
Powerpoint slides on Prazosin Images of Prazosin Photos of Prazosin Podcasts & MP3s on Prazosin Videos on Prazosin
Evidence Based Medicine
Cochrane Collaboration on Prazosin Bandolier on Prazosin TRIP on Prazosin
Clinical Trials
Ongoing Trials on Prazosin at Clinical Trials.gov Trial results on Prazosin Clinical Trials on Prazosin at Google
Guidelines / Policies / Govt
US National Guidelines Clearinghouse on Prazosin NICE Guidance on Prazosin NHS PRODIGY Guidance FDA on Prazosin CDC on Prazosin
Books
Books on Prazosin
News
Prazosin in the news Be alerted to news on Prazosin News trends on Prazosin
Commentary
Blogs on Prazosin
Definitions
Definitions of Prazosin
Patient Resources / Community
Patient resources on Prazosin Discussion groups on Prazosin Patient Handouts on Prazosin Directions to Hospitals Treating Prazosin Risk calculators and risk factors for Prazosin
Healthcare Provider Resources
Symptoms of Prazosin Causes & Risk Factors for Prazosin Diagnostic studies for Prazosin Treatment of Prazosin
Continuing Medical Education (CME)
CME Programs on Prazosin
International
Prazosin en Espanol Prazosin en Francais
Business
Prazosin in the Marketplace Patents on Prazosin
Experimental / Informatics
List of terms related to Prazosin

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Please Join in Editing This Page and Apply to be an Editor-In-Chief for this topic: There can be one or more than one Editor-In-Chief. You may also apply to be an Associate Editor-In-Chief of one of the subtopics below. Please mail us [2] to indicate your interest in serving either as an Editor-In-Chief of the entire topic or as an Associate Editor-In-Chief for a subtopic. Please be sure to attach your CV and or biographical sketch.

Overview

Prazosin, trade names Minipress® and Hypovase®, is a medication used to treat high blood pressure (hypertension). It belongs to the class of alpha-adrenergic blockers, which lower blood pressure by relaxing blood vessels. Specifically, prazosin is selective for the alpha-1 receptors on vascular smooth muscle. These receptors are responsible for the vasoconstrictive action of norepinephrine, which in turn raises blood pressure. By blocking these receptors, prazosin reduces blood pressure.

Other features which add to the therapeutic value of Prazosin

1) The drug is orally active.

2) Unlike other less selective alpha blockers, which also block presynaptic alpha-2 receptors, it doesn't prevent inhibition of noradrenaline release. uninhibited noradrenaline release causes increased reflex tachycardia through the sympathetic baroreflex response that increases cardiac output, prazosin has a minimal effect on cardiac function due to its alpha-1 receptor selectivity.

3) Prazosin is also useful in treating urinary hesitancy associated with prostatic hyperplasia by blocking alpha-1 receptors, which control constriction of both the prostate and ureters.

Side effects of prazosin include orthostatic hypotension, syncope, and nasal congestion. The orthostatic hypotension and syncope are associated with the body's poor ability to control blood pressure without active alpha-adrenergic receptors. Patients on prazosin should be told not to stand up too quickly, since their poor baroreflex may cause them to faint as all their blood rushes to their feet. The nasal congestion is due to dilation of vessels in the nasal mucosa. One phenomenon associated with prazosin is known as the "first dose response", in which the side effects of the drug, especially orthostatic hypotension, are especially pronounced after the first dose. Another Common Side effect of Prazosin(And Doxazosin) is Priapism.[3][4].

This medication has shown to be effective in treating severe nightmares in children, associated with PTSD symptoms.